share_log

Laidlaw & Co. Downgrades MEI Pharma to Hold

Benzinga ·  Jul 23 18:45

Laidlaw & Co. analyst Yale Jen downgrades MEI Pharma (NASDAQ:MEIP) from Buy to Hold.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment